期刊文献+
共找到13,206篇文章
< 1 2 250 >
每页显示 20 50 100
Brain endothelial cyclic GMP-AMP synthase(cGAS)-stimulator of interferon genes(STING)signaling pathway in aging and neurodegeneration
1
作者 Bryan Sun Lulin Li Jian Luo 《Neural Regeneration Research》 SCIE CAS 2025年第7期2005-2007,共3页
The cyclic GMP-AMP synthase(cGAS)-stimulator of interferon genes(STING)signaling pathway has emerged as a key mediator of neuroinflammation.While current studies primarily attribute its effects to neurons and glial ce... The cyclic GMP-AMP synthase(cGAS)-stimulator of interferon genes(STING)signaling pathway has emerged as a key mediator of neuroinflammation.While current studies primarily attribute its effects to neurons and glial cells,emerging research suggests that cGAS-STING signaling may play a critical role in cerebral vasculature,particularly in brain endothelial cells.Therefore,studying the role 7of inflammation caused by the cGAS-STING pathway in brain endothelial cells could provide a more comprehensive understanding of neuroinflammatory disease and new avenues for therapeutic interventions.Here,we review the multifaceted role of global cGAS-STING signaling in various neurological and neuroinflammatory diseases and the potential contribution of cGAS-STING in brain endothelial cells. 展开更多
关键词 STIMULATOR interferon inflammation
暂未订购
The cGAS-STING-interferon regulatory factor 7 pathway regulates neuroinflammation in Parkinson's disease
2
作者 Shengyang Zhou Ting Li +8 位作者 Wei Zhang Jian Wu Hui Hong Wei Quan Xinyu Qiao Chun Cui Chenmeng Qiao Weijiang Zhao Yanqin Shen 《Neural Regeneration Research》 SCIE CAS 2025年第8期2361-2372,共12页
Interferon regulatory factor 7 plays a crucial role in the innate immune response.However,whether interferon regulatory factor 7-mediated signaling contributes to Parkinson's disease remains unknown.Here we report... Interferon regulatory factor 7 plays a crucial role in the innate immune response.However,whether interferon regulatory factor 7-mediated signaling contributes to Parkinson's disease remains unknown.Here we report that interferon regulatory factor 7 is markedly up-regulated in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease and co-localizes with microglial cells.Both the selective cyclic guanosine monophosphate adenosine monophosphate synthase inhibitor RU.521 and the stimulator of interferon genes inhibitor H151 effectively suppressed interferon regulatory factor 7 activation in BV2 microglia exposed to 1-methyl-4-phenylpyridinium and inhibited transformation of mouse BV2 microglia into the neurotoxic M1 phenotype.In addition,si RNA-mediated knockdown of interferon regulatory factor 7 expression in BV2 microglia reduced the expression of inducible nitric oxide synthase,tumor necrosis factorα,CD16,CD32,and CD86 and increased the expression of the anti-inflammatory markers ARG1 and YM1.Taken together,our findings indicate that the cyclic guanosine monophosphate adenosine monophosphate synthase-stimulator of interferon genes-interferon regulatory factor 7 pathway plays a crucial role in the pathogenesis of Parkinson's disease. 展开更多
关键词 cyclic guanosine monophosphate adenosine monophosphate synthase H151 interferon regulatory factor 7 M1 phenotype neurodegenerative disease NEUROINFLAMMATION Parkinson’s disease RU521 STING type I interferon
暂未订购
Ropeginterferonα-2b治疗骨髓增殖性肿瘤的研究进展
3
作者 屠玲榕 黄健 《中国实验血液学杂志》 北大核心 2025年第1期306-310,共5页
Ropeginterferonα-2b是新上市的一种长效聚乙二醇脯氨酸α干扰素,是第一种专门批准用于治疗真性红细胞增多症的干扰素,临床试验和经验发现其可以诱导骨髓增殖性肿瘤患者血液学缓解,控制疾病相关症状,降低JAK2V617F基因突变负荷。与聚... Ropeginterferonα-2b是新上市的一种长效聚乙二醇脯氨酸α干扰素,是第一种专门批准用于治疗真性红细胞增多症的干扰素,临床试验和经验发现其可以诱导骨髓增殖性肿瘤患者血液学缓解,控制疾病相关症状,降低JAK2V617F基因突变负荷。与聚乙二醇干扰素α和羟基脲相比,其药物不良反应发生率和严重程度较低,且给药间隔时间更长,部分低危真性红细胞增多症和骨髓纤维化患者也能从中获益。本文就Ropeginterferonα-2b在骨髓增殖性肿瘤中的最新研究进展作一综述。 展开更多
关键词 骨髓增殖性肿瘤 Ropeginterferonα-2b Α干扰素 治疗
原文传递
Bidirectional regulation of the cyclic guanosine monophosphateadenosine monophosphate synthase-stimulator of interferon gene pathway and its impact on hepatocellular carcinoma
4
作者 Ai-Yu Nie Zhong-Hui Xiao +4 位作者 Jia-Li Deng Na Li Li-Yuan Hao Sheng-Hao Li Xiao-Yu Hu 《World Journal of Gastrointestinal Oncology》 2025年第2期246-261,共16页
BACKGROUND Hepatocellular carcinoma(HCC)ranks as the fourth leading cause of cancerrelated deaths in China,and the treatment options are limited.The cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS... BACKGROUND Hepatocellular carcinoma(HCC)ranks as the fourth leading cause of cancerrelated deaths in China,and the treatment options are limited.The cyclic guanosine monophosphate-adenosine monophosphate synthase(cGAS)activates the stimulator of interferon gene(STING)signaling pathway as a crucial immune response pathway in the cytoplasm,which detects cytoplasmic DNA to regulate innate and adaptive immune responses.As a potential therapeutic target,cGASSTING pathway markedly inhibits tumor cell proliferation and metastasis,with its activation being particularly relevant in HCC.However,prolonged pathway activation may lead to an immunosuppressive tumor microenvironment,which fostering the invasion or metastasis of liver tumor cells.AIM To investigate the dual-regulation mechanism of cGAS-STING in HCC.METHODS This review was conducted according to the PRISMA guidelines.The study conducted a comprehensive search for articles related to HCC on PubMed and Web of Science databases.Through rigorous screening and meticulous analysis of the retrieved literature,the research aimed to summarize and elucidate the impact of the cGAS-STING pathway on HCC tumors.RESULTS All authors collaboratively selected studies for inclusion,extracted data,and the initial search of online databases yielded 1445 studies.After removing duplicates,remaining 964 records were screened.Ultimately,55 articles met the inclusion criteria and were included in this review.CONCLUSION Acute inflammation can have a few inhibitory effects on cancer,while chronic inflammation generally promotes its progression.Extended cGAS-STING pathway activation will result in a suppressive tumor microenvironment. 展开更多
关键词 Hepatocellular carcinoma Cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon gene interferon genes The metastasis of a tumor IMMUNOLOGY
暂未订购
Interferon-gamma signaling pathway:Modulation of key genes in the progression of glioblastoma
5
作者 Enrique Oropeza-Martínez Eva G Palacios Serrato +4 位作者 Sayra X Zamora-Salas Norma A Lira-Rodríguez Sianka’an HZ López-Mignon Maximo B Martinez-Benitez Angeles C Tecalco-Cruz 《World Journal of Biological Chemistry》 2025年第4期52-64,共13页
The canonical signaling of interferon gamma(IFN-γ)through the Janus kinase 1 and 2–signal transducer and activator of transcription 1(STAT1)axis leads to the expression of several interferon-stimulated genes(ISGs),w... The canonical signaling of interferon gamma(IFN-γ)through the Janus kinase 1 and 2–signal transducer and activator of transcription 1(STAT1)axis leads to the expression of several interferon-stimulated genes(ISGs),which have diverse effects depending on the cellular context.In glioblastoma,a highly aggressive primary brain tumor in adults,elements of IFN-γcanonical signaling are deregulated,resulting in the overexpression of STAT1-target ISGs associated with tumor progression.This mini-review highlights key ISGs,including STAT1,interferon regulatory factor 1,programmed death-ligand 1,indoleamine 2,3-dioxygenase 1,and interferon-stimulated gene 15,involved in the pathology of glioblastoma.These genes may serve as valuable biomarkers and have therapeutic potential for targeting IFN-γsignaling in this malignancy. 展开更多
关键词 GLIOBLASTOMA interferon gamma Janus kinases interferon-stimulated genes Signal transducer and activator of transcription 1 interferon regulatory factor 1 B7-H1 antigen Indoleamine-2 3-dioxygenase interferon-stimulated gene 15 Signal transduction
暂未订购
Association of interferon regulatory factor 8 dysregulation with dry eye in Sjögren’s syndrome
6
作者 Jiao Wang Guang-Hong Chu +4 位作者 Zi-Huan Wang Xiao-Yu Cai Si-Yuan Shi Qi-Ping Qing Qi Zhang 《International Journal of Ophthalmology(English edition)》 2025年第8期1456-1463,共8页
AIM:To investigate the expression of interferon regulatory factors(IRFs)in peripheral blood mononuclear cells(PBMCs)of patients with Sjögren’s syndrome-related dry eye(SSDE)and to explore their correlation with ... AIM:To investigate the expression of interferon regulatory factors(IRFs)in peripheral blood mononuclear cells(PBMCs)of patients with Sjögren’s syndrome-related dry eye(SSDE)and to explore their correlation with clinical features,dendritic cell activation,and serological indicators.METHODS:A total of 53 SSDE patients and 62 non-Sjögren’s syndrome dry eye(NSSDE)patients were enrolled.Demographic and clinical data were collected,and comprehensive ophthalmic examinations were performed,including the ocular surface disease index(OSDI)questionnaires,Schirmer I test(SIT),tear break-up time(TBUT),corneal fluorescein staining score(CFS),and in vivo confocal microscopy(IVCM).PBMCs were isolated,and IRFs expression levels were analyzed using Western blotting(WB)and quantitative real-time polymerase chain reaction(qRT-PCR).Serological indicators,including antinuclear antibodies(ANA)and anti-Ro60,anti-Ro52,and anti-La autoantibodies,were detected.Statistical analyses evaluated correlations between IRFs expression and clinical parameters.RESULTS:Compared to NSSDE,the relative mRNA and protein expression of the IRF-8 was significantly upregulated in patients with SSDE(P<0.001),whereas no significant differences were observed in IRF-1,IRF-3,IRF-5,and IRF-7(P=0.12,P=0.10,P=0.66,P=0.96).Correlation analysis revealed that IRF-8 expression was positively associated with CFS and OSDI scores(r=0.57,r=0.38,both P<0.05).Moreover,IRF-8 expression correlated with corneal dendritic cell(DC)density and size,and the number of dendrites(r=0.43,r=0.40,r=0.65,all P<0.05).IRF-8 expression was significantly elevated in patients positive for anti-Ro60,anti-Ro52 and anti-La autoantibodies(P<0.05).CONCLUSION:In SSDE,IRF-8 is upregulated and associated with clinical features,DC activation,and serological indicators.These findings suggest that IRF-8 plays a critical role in SSDE pathogenesis and may serve as a potential therapeutic target for diagnosis and treatment. 展开更多
关键词 interferon regulatory factors Sjögren’s syndrome dry eye
原文传递
Retreatment hepatitis B surface antigen clearance prediction model identifies pegylated interferon alpha candidates in chronic hepatitis B
7
作者 Yan-Chao Fu Jun Li +8 位作者 Jia-Yin Wang Yi-Wen Zhang Fei Yan Jing Chen Qin Du Chao Yang Jing Liang Qing Ye Hui-Ling Xiang 《World Journal of Gastroenterology》 2025年第44期94-106,共13页
BACKGROUND Chronic hepatitis B(CHB)patients rarely achieve functional cure with initial pegylated interferon alpha-2b(Peg-IFNα-2b)therapy.Validated tools to guide retreatment candidates are lacking.We hypothesized th... BACKGROUND Chronic hepatitis B(CHB)patients rarely achieve functional cure with initial pegylated interferon alpha-2b(Peg-IFNα-2b)therapy.Validated tools to guide retreatment candidates are lacking.We hypothesized that clinical indicators predict hepatitis B surface antigen(HBsAg)clearance during retreatment.AIM To develop a prediction model for HBsAg clearance in Peg-IFNα-2b retreatment.METHODS In this retrospective cohort study,we enrolled 135 CHB/compensated cirrhosis patients receiving Peg-IFNα-2b retreatment after initial non-clearance at Tianjin University Central Hospital(2017-2025).Predictors were identified through univariate Cox,least absolute shrinkage and selection operator,and multivariate Cox regression.Model performance was assessed via receiver operating characteristic analysis and Harrell’s C-index,with risk stratification by X-tile optimization.RESULTS HBsAg clearance rate was 20.74%(28/135).Independent predictors included:Combination nucleos(t)ide analogue(NA)therapy during initial treatment[hazard ratio(HR)=0.276,95%confidence interval(CI):0.092-0.833],baseline HBsAg at retreatment(HR=0.571,95%CI:0.410-0.795),HBsAg decline after initial treatment(HR=2.050,95%CI:1.108-3.793),and treatment interval(HR=1.013/week,95%CI:1.008-1.018).The retreatment HBsAg clearance prediction score(RHCP-S)demonstrated area under the curve of 0.920(95%CI:0.863-0.946),sensitivity of 92.3%,specificity of 79.3%.Clearance rates differed significantly:RHCP-S challenge group(≤74 points):3.45%,RHCP-S probable group(74-110 points):29.63%,RHCP-S dominant group(≥110 points):80.95%(P<0.001).CONCLUSION The overall HBsAg clearance rate with Peg-IFNα-2b retreatment was 20.74%(28/135).The RHCP-S model identifies optimal retreatment candidates(≥110 points)with 80.95%clearance probability,associated with the absence of combination NA therapy during initial treatment,greater initial HBsAg decline,longer intervals,and lower retreatment HBsAg. 展开更多
关键词 Chronic hepatitis B RETREATMENT Pegylated interferon alpha Hepatitis B surface antigen clearance Prediction model
暂未订购
Jianpi Yifei Tongluo recipe(健脾益肺通络方剂)attenuates inflammation by promoting the expression of interferon regulatory factor 4 in the rat model of chronic obstructive pulmonary disease
8
作者 WANG Wei LONG Qi +1 位作者 FU Ling WU Haiqiao 《Journal of Traditional Chinese Medicine》 2025年第5期1048-1058,共11页
OBJECTIVE:To examine the effects of the Jianpi Yifei Tongluo recipe(健脾益肺通络方剂,JYTR)on chronic obstructive pulmonary disease(COPD)within an animal model and to elucidate its anti-inflammatory mechanisms.METHODS:... OBJECTIVE:To examine the effects of the Jianpi Yifei Tongluo recipe(健脾益肺通络方剂,JYTR)on chronic obstructive pulmonary disease(COPD)within an animal model and to elucidate its anti-inflammatory mechanisms.METHODS:In this study,we utilized cigarette smoke(CS)exposure and lipopolysaccharide(LPS)-induced models of COPD in rats to evaluate the effects of the JYTR on airway inflammation.Sprague-Dawley rats were randomly assigned to various groups:control,model,budesonide,synbiotics,and low,medium,and high JYTR.Pulmonary function was gauged using an animal volumetric tracer.Pathological alterations in lung tissue were examined under a light microscope.To ascertain cytokine production,we conducted enzyme-linked immunosorbent assay tests,and we employed Western blotting to measure the expression levels of interferon regulatory factor 4(IRF4),arginase 1(Arg1),inducible nitric oxide synthase(iNOS),nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor,alpha(IKB-α),and P65.RESULTS:Compared to the control group,rats in the COPD model group exhibited significantly compromised pulmonary function and severe inflammatory pathology in the lungs.Treatment with budesonide,synbiotics,and the JYTR markedly improved pulmonary function and diminished the production of inflammatory cytokines transforming growth factor-beta(TGF-β),tumor necrosis factor-alpha(TNF-α),and interleukin-6(IL-6).These improvements were particularly notable in the budesonide group and the high-dose JYTR group.Additionally,the JYTR increased the expression of IRF4 and upregulated the protein expression of Arg1,while concurrently downregulating the protein expression of iNOS,phosphorylated IKB-α,and phosphorylated P65.CONCLUSION:Our current study reveals that JYTR can mitigate inflammatory lung injury,enhance lung function,and lower levels of inflammatory cytokines induced by CS or LPS exposure in COPD model rats.The mechanism behind its anti-inflammatory effect likely involves the regulation of IRF4 expression and M2 polarization through the nuclear factor kappa-light-chain-enhancer of activated B cells signaling pathway. 展开更多
关键词 cigarette smoking INFLAMMATION pulmonary disease chronic obstructive interferon regulatory factors Jianpi Yifei Tongluo recipe
原文传递
联合应用干扰素-α雾化方式给药对小儿喘息性支气管的效果及安全性
9
作者 向荣梅 罗亚辉 +8 位作者 严军平 张勇刚 周君 聂少风 朱琳 周敏 张春珍 易江 张钰 《中外医学研究》 2026年第1期49-51,55,共4页
目的:分析小儿喘息性支气管炎治疗中联合应用干扰素-α雾化方式给药的效果及安全性。方法:选取2022年12月—2024年12月汉川市人民医院收治的130例小儿喘息性支气管炎患儿为研究对象,按照随机抽签法分为两组,每组各65例,对照组采用基础... 目的:分析小儿喘息性支气管炎治疗中联合应用干扰素-α雾化方式给药的效果及安全性。方法:选取2022年12月—2024年12月汉川市人民医院收治的130例小儿喘息性支气管炎患儿为研究对象,按照随机抽签法分为两组,每组各65例,对照组采用基础对症治疗,分析组联合应用注射用人干扰素α1b治疗,比较两组症状积分、血嗜酸性粒细胞比率(EO%)、外周血白细胞计数(WBC)以及血清白介素2(IL-2)、白介素4(IL-4)、白介素5(IL-5)水平改善情况、总体疗效以及不良反应率。结果:分析组总有效率明显高于对照组,差异有统计学意义(P<0.05);治疗后,两组症状积分、EO%、WBC以及IL-2、IL-4、IL-5水平均明显降低,且分析组低于对照组,差异有统计学意义(P<0.05);分析组不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论:小儿喘息性支气管炎治疗中联合应用注射用人干扰素α1b雾化方式具有良好的效果,可有效促进炎症、细胞因子水平改善,并减少不良反应发生。 展开更多
关键词 小儿喘息性支气管炎 干扰素-Α 雾化方式 炎症 细胞因子 安全性
暂未订购
胃癌三级淋巴结构ARHGAP12表达分析
10
作者 季湧 陈诗涵 +8 位作者 徐晓凤 吕剑 龙聪 蔡圣强 徐传奇 陈静 朱淼琳 朱伟 高峰 《江苏大学学报(医学版)》 2026年第1期30-35,43,共7页
目的:探究胃癌三级淋巴结构(tertiary lymphatic structures,TLS)区域内Rho GTP酶激活蛋白12(Rho GTPase activating protein 12,ARHGAP12)表达水平及对肿瘤免疫反应的影响。方法:通过TCGA数据库分析胃腺癌(n=414)与正常胃组织(n=211)中... 目的:探究胃癌三级淋巴结构(tertiary lymphatic structures,TLS)区域内Rho GTP酶激活蛋白12(Rho GTPase activating protein 12,ARHGAP12)表达水平及对肿瘤免疫反应的影响。方法:通过TCGA数据库分析胃腺癌(n=414)与正常胃组织(n=211)中ARHGAP12 mRNA表达差异。免疫印迹法检测12例胃腺癌及癌旁组织中ARHGAP12蛋白表达水平。采用多重免疫荧光检测胃癌组织切片TLS和肿瘤引流淋巴结(tumor-draining lymph node,TDLN)中ARHGAP12蛋白表达。Hallmark及KEGG信号通路富集分析ARHGAP12 mRNA表达与免疫相关通路活化的相关性。采用免疫组化检测28例胃癌患者肿瘤组织切片中ARHGAP12蛋白表达水平,并结合临床数据分析细胞因子表达水平与ARHGAP12免疫组化染色评分的相关性。KM plotter数据库分析胃癌患者ARHGAP12 mRNA水平与预后的关系。结果:TCGA数据库分析结果显示,胃癌组织中ARHGAP12 mRNA表达较正常胃组织显著升高(P<0.001)。免疫印迹结果显示,胃腺癌及癌旁组织样本中ARHGAP12蛋白相对表达水平无统计学差异(P>0.05)。多重免疫荧光结果显示,ARHGAP12蛋白在胃癌细胞、TLS和TDLN区域呈高表达(P<0.05)。Hallmark及KEGG信号通路富集分析结果提示,ARHGAP12 mRNA表达参与干扰素应答途径的激活及抗原呈递过程。此外,ARHGAP12免疫组化染色高评分与胃癌患者术前血清中IFN-γ水平呈正相关(P<0.05)。胃癌组织中ARHGAP12 mRNA高表达与总生存时间长呈正相关(P<0.05)。结论:ARHGAP12在胃癌TLS中呈高表达,且其与干扰素-γ相关抗肿瘤免疫途径活化呈正相关。 展开更多
关键词 胃癌 Rho GTP酶激活蛋白12(ARHGAP12) 三级淋巴结构 干扰素反应 肿瘤引流淋巴结
暂未订购
Assessment of natural and interleukin-2-induced production of interferon-gamma in patients with liver diseases
11
作者 陈士葆 缪晓辉 +1 位作者 杜平 吴清璇 《World Journal of Gastroenterology》 SCIE CAS CSCD 1996年第3期173-175,共3页
AIMS To clarify whether the lower interferon gamma (IFNγ) production by lymphocytes in patients with liver diseases is due to defects of lymphocytes themselves or of other cofactors such as interleukin-2(IL-2). METHO... AIMS To clarify whether the lower interferon gamma (IFNγ) production by lymphocytes in patients with liver diseases is due to defects of lymphocytes themselves or of other cofactors such as interleukin-2(IL-2). METHODS Peripheral blood mononuclear cells (PBMCs) from patients with various liver diseases were cultured with or without PHA and IL-2. The cells were harvested and counted and the su- pernatants were tested for IFNγ by a sensitive and quantitative ABC-ELISA. RESULTS IFNγ was not round in serum samples from patients as well as normal individuals. However,in supernatants of non-in- duced and induced PBMCs,IFN7 was detected by ABC-ELISA. In non-induced PBMCs (group 1),the content of IFNγ in super- natants from control,CAH,CPH and HCC was 8.72 μg/L, 5.03 μg/L,6.02 μg/L and 4.91 μg/L respectively. The pro- duction of IFNγ in liver disease was significantly decreased,com- pared to control. In group 2 in which PBMCs were stimulated with PHA,the content of IFNγ was 22.71,17.12,14.54 and 17.63 μg/L respectively. In group 3 in which PBMCs were in- duced by IL-2,the amount of IFN7 in supernatant from control (60.67 μg/L) was much larger than those from CAH (21.70 μg/ L),CPH (24.00 μg/L) and HCC (19.15 μg/L) (P<0.01). Comparing the amount of IFNγ in group 3 (IL-2-induced) with that in group 1 (non-induced),we found that IFNγ production was en- hanced by nearly 4 folds in liver diseases and by over 7 folds in control,Whereas the number of PBMCs,whether from liver dis- eases or from control,was increased by only approximately 3 folds. CONCLUSIONS The decreased production of IFNγ in liver dis- eases including HCC is mainly due to endogenous defects of lym- phocytes though the defects of stimulating cofactors such as IL-2 may also be involved. 展开更多
关键词 liver disease INTERLEUKIN-2 interferon type
暂未订购
Cloning and Sequence Analysis of Interferon γ-2β Full-length cDNA in Cyprinus carpio L.
12
作者 陈义龙 冯祥汝 +6 位作者 赵晓 王文东 张俊辉 杨振国 孙真 贾生美 卢强 《Agricultural Science & Technology》 CAS 2012年第6期1230-1233,共4页
[Objective] The research aimed to carry out the cloning, identification and sequence analysis of full-length cDNA of carp interferon γ-2β (IFNγ-2β). [Method] The cDNA library of peripheral blood leucocytes which... [Objective] The research aimed to carry out the cloning, identification and sequence analysis of full-length cDNA of carp interferon γ-2β (IFNγ-2β). [Method] The cDNA library of peripheral blood leucocytes which were separated from carp and stimulated with mitogen was screened by a probe labeled with DIG. The IFNγ- 2β EST sequence was picked out from the constructed cDNA library of peripheral blood leucocyte, and the full length of carp interferon γ-2β was cloned. In addition, the sequence analysis was carried out. [Result] Three positive clones were obtained. Sequence analysis indicated that the sequence had a 119 bp 5’-UTR and a 218 bp 3’-UTR, and the open reading frame (ORF)of this gene was 537 bp which putatively coded 178 amino acids and there were several instable motifs for mRNA (ATTTA) in the 3’-untranslated region. Its homology with IFN from GenBank was up to 97% . Analysis on protein sequence and structure showed that the predicted protein sequence was identified as an IFN family signature. [Conclusion] The research laid the foundation for further studying the expression manner, function characteristic and regulation mechanism of IFNγ-2β in vivo and the action mechanism in the inflammatory reaction, emergency reaction and immune response. 展开更多
关键词 Common carp interferon gamma-2β CLONING Sequencing analysis
在线阅读 下载PDF
Effects of γ interferon on hepatic fibrosis of schistosoma japonicum infected mice *
13
作者 贺永文 刘薇 +1 位作者 曾令兰 罗端德 《World Journal of Gastroenterology》 SCIE CAS CSCD 1997年第1期18+9-11,9-11,共4页
AIM To probe the effect of γ IFN on hepatic fibrosis in schistosomiasis japonica.
关键词 Schistosomiasis Liver cirrhosis interferon type Granuloma Extracellular matrix
暂未订购
兔干扰素α和白介素2重组融合蛋白菌株构建与蛋白表达
14
作者 王慈 王海欣 +2 位作者 李霄 袁万哲 李杰峰 《养殖与饲料》 2026年第1期100-105,共6页
[目的]本试验拟表达外源兔白细胞介素2(Interleukin-2,IL-2)和干扰素α(Interferon-alpha,IFN-α)重组蛋白,为兔病毒性疾病防治提供科学依据。[方法]参考GenBank数据库中的IL-2和IFN-α基因序列,去除信号肽后使用linker连接成为嵌合基因... [目的]本试验拟表达外源兔白细胞介素2(Interleukin-2,IL-2)和干扰素α(Interferon-alpha,IFN-α)重组蛋白,为兔病毒性疾病防治提供科学依据。[方法]参考GenBank数据库中的IL-2和IFN-α基因序列,去除信号肽后使用linker连接成为嵌合基因,将其克隆至原核表达载体pET-32a中并进行密码子优化,转化至E.coli BL21感受态细胞培养并诱导表达,通过SDS-PAGE对表达产物进行分析。[结果]pET32a-RaIFNα-IL2在约1073 bp处有明显条带,表明质粒构建成功。pET32a-RaIFNα-IL2-BL21菌株在扩大培养3.5 h,1.0 mM IPTG诱导4 h后表达量较高,相对分子质量约为49.1 ku,主要以包涵体形式存在。[结论]成功构建了兔IL-2和IFN-α的重组蛋白。 展开更多
关键词 白介素2 干扰素Α 原核表达 可溶性鉴定 分离纯化
在线阅读 下载PDF
血清干扰素调节因子1在类风湿关节炎中的临床意义
15
作者 李荣琪 李宇轩 +2 位作者 张燕 李昕 魏蔚 《天津医药》 2026年第1期84-87,共4页
目的探讨血清干扰素调节因子1(IRF1)在类风湿关节炎(RA)中的临床意义。方法纳入30例RA患者(RA组)和30例健康者(对照组)作为研究对象,采用酶联免疫吸附试验检测受试者血清IRF1、抗环瓜氨酸肽抗体(抗CCP抗体)水平,收集RA患者的临床资料及... 目的探讨血清干扰素调节因子1(IRF1)在类风湿关节炎(RA)中的临床意义。方法纳入30例RA患者(RA组)和30例健康者(对照组)作为研究对象,采用酶联免疫吸附试验检测受试者血清IRF1、抗环瓜氨酸肽抗体(抗CCP抗体)水平,收集RA患者的临床资料及实验室指标,如健康评估问卷(HAQ)、白细胞介素-6(IL-6)、28个关节疾病活动指数(DAS28-ESR)评分等。RA患者以单药甲氨蝶呤起始治疗(10~20 mg/周)1~3个月,分别于第4和12周经DAS28-ESR评估疗效,必要时调整治疗方案;期间可短期联用小剂量激素或非甾体抗炎药以快速缓解症状。比较RA组和对照组以及RA组治疗前后的血清IRF1和抗CCP抗体水平;分析IRF1与RA患者临床和实验室指标之间的相关性;受试者工作特征(ROC)曲线评估IRF1对RA的诊断价值。结果与对照组相比,RA组血清IRF1、抗CCP抗体水平均升高。RA组血清IRF1浓度与抗CCP抗体、红细胞沉降率、C反应蛋白、DAS28-ESR评分、关节压痛计数、关节肿胀计数、疼痛视觉模拟评分、HAQ、IL-6、类风湿因子无相关性(P>0.05)。接受MTX治疗4周后RA患者血清IRF1水平较治疗前差异无统计学意义(P>0.05);至第12周血清IRF1水平较治疗前和治疗后4周均降低(P<0.05)。血清IRF1与抗CCP抗体联合诊断RA的曲线下面积为0.968(95%CI:0.924~1.000),优于二者单独诊断(AUC分别为0.831、0.852)。结论RA患者血清IRF1水平增高,对RA有一定的诊断价值,且与血清抗CCP抗体联合诊断效能更高。 展开更多
关键词 关节炎 类风湿 干扰素调节因子1 自身抗体 甲氨蝶呤 抗CCP抗体
暂未订购
Acute Toxicity of Recombinant Porcine Interferon-alpha
16
作者 王兴满 赵俊 +6 位作者 李京培 刘伯玉 汤仁树 俞海洋 胡勇 王燕来 王明丽 《Animal Husbandry and Feed Science》 CAS 2009年第4期38-40,46,共4页
To observe the acute toxicity of recombinant porcine interferen-alpha (IFN-alpha) in mice and thus provide a basis for the clinical safety. [Method] According to the principles of acute toxicity, all the mice were d... To observe the acute toxicity of recombinant porcine interferen-alpha (IFN-alpha) in mice and thus provide a basis for the clinical safety. [Method] According to the principles of acute toxicity, all the mice were divided into two major groups (intraperitoneally injected group and intramuscularly injected group) respectively at high dose, moderate dose and low dose. And the normal control group was also set up. Within 14 d after administration, the behavior of mouse and the degree of toxicity were continuously observed. The hematological indexes and biochemical indexes of blood were detected to obtain the preliminary toxicity data of the recombinant porcine IFN-alpha. And at the end of the experiment, mice were sacrificed for autopsy. [ Result] There was not significant difference in external performance, behavioral characteristics, body temperature, weight, pathological anatomy of visceral organs, hematological indexes and biochemical indexes between the experimental groups and the control group. [ Conclusion] The highest dose of porcine interferon (5.0 x 10s IU per mouse) in this experiment or the dose lower than this dosage should not have significant toxic effects on mice, and the recombinant porcine IFN-alpha is safe in clinical application. 展开更多
关键词 Recombinant porcine interferon-alpha Acute toxicity MICE
在线阅读 下载PDF
Integrative omics and multi-cohort identify IRF1 and biological targets related to sepsis-associated acute respiratory distress syndrome
17
作者 Jiajin Chen Ruili Hou +9 位作者 Xiaowen Xu Ning Xie Jiaqi Tang Yi Li Xiaoqing Nie Nuala J.Meyer Li Su David C.Christiani Feng Chen Ruyang Zhang 《Journal of Biomedical Research》 2026年第1期11-22,共12页
Interferon-related genes are involved in antiviral responses,inflammation,and immunity,which are closely related to sepsis-associated acute respiratory distress syndrome(ARDS).We analyzed 1972 participants with genoty... Interferon-related genes are involved in antiviral responses,inflammation,and immunity,which are closely related to sepsis-associated acute respiratory distress syndrome(ARDS).We analyzed 1972 participants with genotype data and 681 participants with gene expression data from the Molecular Epidemiology of ARDS(MEARDS),the Molecular Epidemiology of Sepsis in the ICU(MESSI),and the Molecular Diagnosis and Risk Stratification of Sepsis(MARS)cohorts in a three-step study focusing on sepsis-associated ARDS and sepsis-only controls.First,we identified and validated interferon-related genes associated with sepsis-associated ARDS risk using genetically regulated gene expression(GReX).Second,we examined the association of the confirmed gene(interferon regulatory factor 1,IRF1)with ARDS risk and survival and conducted a mediation analysis.Through discovery and validation,we found that the GReX of IRF1 was associated with ARDS risk(odds ratio[OR_(MEARDS)]=0.84,P=0.008;OR_(MESSI)=0.83,P=0.034).Furthermore,individual-level measured IRF1 expression was associated with reduced ARDS risk(OR=0.58,P=8.67×10^(-4)),and improved overall survival in ARDS patients(hazard ratio[HR_(28-day)]=0.49,P=0.009)and sepsis patients(HR_(28-day)=0.76,P=0.008).Mediation analysis revealed that IRF1 may enhance immune function by regulating the major histocompatibility complex,including HLA-F,which mediated more than 70%of protective effects of IRF1 on ARDS.The findings were validated by in vitro biological experiments including time-series infection dynamics,overexpression,knockout,and chromatin immunoprecipitation sequencing.Early prophylactic interventions to activate IRF1 in sepsis patients,thereby regulating HLA-F,may reduce the risk of ARDS and mortality,especially in severely ill patients. 展开更多
关键词 acute respiratory distress syndrome SEPSIS interferon regulatory factor 1 causal inference immunity
暂未订购
慢性乙型肝炎抗病毒治疗安全性研究进展
18
作者 王媛慧 张清 +1 位作者 李歆 苏钰文 《中国药物警戒》 2026年第1期115-120,共6页
目的通过对慢性乙型肝炎抗病毒治疗药物的临床安全性分析,为此类适应证的临床合理用药与药物研发提供参考。方法基于PubMed、中国知网和万方数据库2020年1月至2025年6月的相关文献,对已上市品种和临床研发阶段相关药物的研究进展进行分... 目的通过对慢性乙型肝炎抗病毒治疗药物的临床安全性分析,为此类适应证的临床合理用药与药物研发提供参考。方法基于PubMed、中国知网和万方数据库2020年1月至2025年6月的相关文献,对已上市品种和临床研发阶段相关药物的研究进展进行分析,并对其单独用药和联合用药的安全性进行探讨。结果已上市的核苷(酸)类似物在安全性方面表现尚可,但长期使用时需对肾毒性、骨代谢影响、妊娠不良事件,以及血脂异常等方面保持警惕;干扰素治疗需要额外关注对血液系统、神经精神和自身免疫性疾病的影响。对于临床研发过程中的试验用药物,需特别关注肝功能异常、免疫相关不良反应、注射部位的不良反应等。结论核苷(酸)类似物在抑制病毒复制、改善肝脏组织学、降低肝细胞癌的发生率方面获益显著,虽然不良事件涉及多个系统,但整体发生率较低且严重程度较轻。鉴于其长期使用的特性,仍需持续关注其安全性问题。干扰素治疗应在有资质的医生的指导下进行,并密切监测不良反应。未来药物研发聚焦于靶向病毒生命周期关键环节或宿主免疫调控,为疾病完全治愈提供更多安全且高效的选择。 展开更多
关键词 慢性乙型肝炎 抗病毒药物 核苷(酸)类似物 干扰素 药品不良反应
暂未订购
细胞因子对系统性儿童特发性关节炎合并噬血细胞综合征的早期诊断价值
19
作者 张晓琪 吴尉明 +3 位作者 胡妮 陈天舒 潘秋辉 李怀远 《检验医学与临床》 2026年第1期80-87,共8页
目的通过分析系统性儿童特发性关节炎(sJIA)合并噬血细胞综合征(MAS)患儿的临床检测指标,探索早期诊断标志物,为临床诊疗提供依据和指导。方法选取2022年8月至2024年12月该中心收治的15例sJIA合并MAS患儿作为sJIA-MAS组,另选取同期该中... 目的通过分析系统性儿童特发性关节炎(sJIA)合并噬血细胞综合征(MAS)患儿的临床检测指标,探索早期诊断标志物,为临床诊疗提供依据和指导。方法选取2022年8月至2024年12月该中心收治的15例sJIA合并MAS患儿作为sJIA-MAS组,另选取同期该中心收治的35例单纯sJIA患儿作为sJIA组。通过医院电子病历系统收集2组患儿的基线资料,包括年龄、性别、临床表现及血常规、常规生化指标和15种细胞因子的检查结果,并统计分析这些指标在2组间的差异。绘制受试者工作特征(ROC)曲线分析细胞因子对sJIA合并MAS的早期诊断价值,再将约登指数前3的细胞因子用于并联和串联试验,进一步进行ROC曲线分析。结果sJIA-MAS组转氨酶、乳酸脱氢酶、白细胞介素(IL)-8、IL-18、干扰素(IFN)-α、肿瘤坏死因子(TNF)-β、IL-2受体(IL-2R)、IL-6、IL-10、IL-17、IFN-γ水平均明显高于sJIA组,骨髓嗜血现象、肝肿大、脾肿大及血清转氨酶升高发生率均高于sJIA组,差异均有统计学意义(P<0.05);sJIA-MAS组白细胞计数、血小板计数、清蛋白水平均明显低于sJIA组,差异均有统计学意义(P<0.05)。ROC曲线分析结果显示,IFN-γ、IL-10、IL-2R、IL-6、IL-17、IL-8、IL-18、IFN-α、TNF-β诊断sJIA合并MAS的曲线下面积(AUC)分别为0.935、0.878、0.859、0.888、0.874、0.723、0.743、0.768、0.817。在各项指标联合检测中,IFN-γ+IL-10的并联检测显示出良好的早期筛查能力,表现出极高的灵敏度(100.0%)和较大的AUC(0.886)。而串联检测的组合均表现出较高的特异度,其中IFN-γ+IL-6的串联检测展现出最佳的平衡性,AUC为0.890,灵敏度为86.7%,特异度为91.4%;IL-10+IL-6的串联检测表现其次,AUC为0.886,灵敏度为80.0%,特异度为97.1%。结论sJIA患儿临床发生肝脾肿大、血清转氨酶升高、骨髓噬血现象时需考虑是否合并MAS,细胞因子及实验室指标水平的变化可能与MAS的发生密切相关,IFN-γ、IL-10、IL-2R、IL-6、IL-17检测在MAS的早期诊断中具有较高的应用价值。通过串联和并联检测,多个组合能够有效提高诊断的灵敏度和特异度,为MAS的早期诊断提供了有效的诊断工具,但结果的可靠性需通过扩大样本量进一步验证。 展开更多
关键词 系统性儿童特发性关节炎 噬血细胞综合征 细胞因子 干扰素-Γ 肿瘤坏死因子-α
暂未订购
血清CCL19、IL-17、IFN-α水平趋势变化在系统性红斑狼疮患者疾病转归中的预测价值
20
作者 郭海军 齐媛媛 董鹏飞 《四川生理科学杂志》 2026年第1期59-61,72,共4页
目的:探讨系统性红斑狼疮(Systemic lupus erythematosus,SLE)患者血清趋化因子配体19(C-C chemokine ligand 19,CCL19)、白细胞介素-17(interleukin-17,IL-17)、干扰素-α(Interferon-α,IFN-α)水平的变化及对疾病转归的预测价值。方... 目的:探讨系统性红斑狼疮(Systemic lupus erythematosus,SLE)患者血清趋化因子配体19(C-C chemokine ligand 19,CCL19)、白细胞介素-17(interleukin-17,IL-17)、干扰素-α(Interferon-α,IFN-α)水平的变化及对疾病转归的预测价值。方法:选取2022年1月至2024年1月我院收治的SLE患者87例作为研究组,根据疾病活动度将患者分为基本无活动(22例)、轻度活动(26例)、中度活动(21例)、重度活动(18例),另选取同期87例健康体检者作为对照组。根据治疗后3 m疾病转归情况将患者分为转归良好(58例)、转归不良(29例)两个亚组。比较两组入院时血清CCL19、IL-17、IFN-α水平,分析入院时血清CCL19、IL-17、IFN-α水平与SLEDAI-2K评分的相关性,比较不同疾病转归患者血清CCL19、IL-17、IFN-α水平,分析转归不良的影响因素,评估血清CCL19、IL-17、IFN-α水平对转归不良的预测价值。结果:研究组入院时血清CCL19、IL-17、IFN-α水平高于对照组(P<0.05);不同疾病活动度患者血CCL19、IL-17、IFN-α水平比较:基本无活动<轻度活动<中度活动<重度活动(P<0.05);入院时血清CCL19、IL-17、IFN-α水平与SLEDAI-2K评分均呈正相关(P<0.05);转归不良亚组治疗后血清CCL19、IL-17、IFN-α水平均高于转归良好亚组(P<0.05)。治疗3 m后,血清CCL19、IL-17、IFN-α水平为疾病转归不良的独立危险因素(P<0.05);三者水平联合预测转归不良的曲线下面积(Area under the crve,AUC)大于单独指标预测(P<0.05)。结论:血清CCL19、IL-17、IFN-α水平与SLE患者疾病转归情况关系密切,其水平可预测疾病转情况,且联合检测可提高预测效能。 展开更多
关键词 系统性红斑狼疮 趋化因子配体19 白细胞介素-17 干扰素-Α 疾病转归
暂未订购
上一页 1 2 250 下一页 到第
使用帮助 返回顶部